1 Pain (mean score) |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
1.1 Clobetasol + miconazole vs clobetasol + placebo |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
1.2 Dexamethasone + nystatin + curcumin vs dexamethasone + nystatin + placebo |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
1.3 Triamcinolone vs triamcinolone + glucosamine sulphate |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2 Clinical score |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
2.1 Clobetasol + miconazole vs clobetasol + placebo |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.2 Dexamethasone + nystatin + curcumin vs dexamethasone + nystatin + placebo |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.3 Triamcinolone vs triamcinolone + glucosamine sulphate |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3 Clinical resolution |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
3.1 Dexamethasone + mycostatin vs dexamethasone alone |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.2 Dexamethasone + nystatin + curcumin vs dexamethasone + nystatin + placebo |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4 Adverse effects |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.1 Clobetasol + miconazole vs clobetasol + placebo |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4.2 Dexamethasone + nystatin + curcumin vs dexamethasone + nystatin + placebo |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |